Company: INDP
Filing Date: 2025-06-23
Form Type: DEF 14A
Source: 0001641172-25-016071
Chunk: 11

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-23
Form: DEF 14A
Chunk 11
---
 to vote on a proposal. Abstentions are counted as present and entitled to vote for purposes of determining
a quorum but will have no effect on the outcome of voting.

What are broker non-votes and do they count for determining a quorum?

Generally, broker non-votes occur when shares
held by a broker in “street name” for a beneficial owner are not voted with respect to a particular proposal because the
broker (1) has not received voting instructions from the beneficial owner and (2) lacks discretionary voting power to vote those shares.
A broker is entitled to vote shares held for a beneficial owner on “routine” matters without instructions from the beneficial
owner of those shares. On the other hand, absent instructions from the beneficial owner of such shares, a broker is not entitled to vote
shares held for a beneficial owner on “non-routine” matters, such as the approval of the Issuance Proposal or the Related
Party Proposal. Because the only matters to be voted on at the Special Meeting are “non-routine” matters, broker non-votes
will not count for purposes of determining whether a quorum is present.

Where can I find the voting results of the Special Meeting?

We plan to announce preliminary voting results
at the Special Meeting, and we will report the final results in a Current Report on Form 8-K, which we intend to file with the SEC after
the Special Meeting.

<div align='center'>6

PROPOSALs TO BE VOTED ON</div>

PROPOSAL 1: ISSUANCE PROPOSAL

We are seeking stockholder approval, for purposes
of complying with Nasdaq Listing Rule 5635(d), of the issuance of (i) shares of our common stock underlying Notes issued or issuable
in the ongoing Private Placement, and (ii) shares of common stock issuable upon exercise of certain warrants including Common Warrants,
Pre-funded Warrants and Placement Agent Warrants, each of which is issuable in the Private Placement.

The information set forth in this Proposal No. 1
is qualified in its entirety by reference to the full text of the form of Purchase Agreements (as defined below), form of Note, the form
of Warrant and the form of PAA (as defined below), attached as exhibits 10.1, 10.2, 10.3 and 10.4, respectively, to our Current Report
on Form 8-K filed with the SEC on June 12,